Form D · Biotechnology
Histogen Inc.
San Diego, CA · CIK 0001645829
Offering snapshot reported Sep 18, 2019 · SEC filing
- Reported sold
- $15.3M Offering amount: $30M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 10, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$6,000,000 → $15,326,531
- Reported investors1 → 47
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2019 | Amendment | $15,326,531 | $9,326,531vs Aug 29, 2016 | 47 | SEC filing |
| Aug 29, 2016 | Initial | $6,000,000 | No comparison | 1 | SEC filing |
| Jun 29, 2015 | Amendment | $5,249,175 | $5,249,175vs Jun 24, 2015 | 34 | SEC filing |
| Jun 29, 2015 | Amendment | $9,486,075 | $9,486,075vs Jun 24, 2015 | 65 | SEC filing |
| Jun 29, 2015 | Amendment | $10,391,500 | $10,391,500vs Jun 24, 2015 | 2 | SEC filing |
| Jun 29, 2015 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jun 24, 2015 | Initial | $0 | No comparison | 2 | SEC filing |
| Jun 24, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 24, 2015 | Initial | $0 | No comparison | 34 | SEC filing |
| Jun 24, 2015 | Initial | $0 | No comparison | 65 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-269733
Source: Form D, filed Sep 18, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Chang | Director |
| David Crean | Director |
| Jonathan Jackson | Director |
| Gail Naughton | Director, Executive |
| Richard Pascoe | Director, Executive |
| Brian Satz | Director |
| Yizhuo Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10655 Sorrento Valley Road
San Diego, CA, 92121
San Diego, CA, 92121